Urogen Pharma Ltd. (URGN)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on March 18, 2025, 4:54 pm based on SEC 13F filings Last update: March 18, 2025, 4:54 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Adage Capital Management Phill Gross And Robert Atchinson	2,928,086	$31,184,116	-22%	0.05%
2.	Vestal Point Capital Ryan Wilder	1,630,000	$17,359,500	+308%	1.02%
3.	Nantahala Capital Management Wilmot B. Harkey And Daniel Mack	1,371,638	$14,607,945		0.62%
4.	SilverArc Capital Devesh Gandhi	1,120,473	$11,933,037	+25%	2.61%
5.	Leucadia National Ian Cumming And Joseph Steinberg	965,929	$10,287,144	+1%	0.06%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Schoenberg	$13.10	160	Officer	21,997	2021-11-18	Filing
Henderson	$15.85	2,500	Officer	2,500	2021-05-17	Filing
Smith	$15.71	2,500	Officer	2,500	2021-05-17	Filing
Barrett	$18.50	10,000	Officer	229,117	2020-12-14	Filing
Barrett	$28.00	7,530	Officer	16,548	2019-11-21	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Schoenberg	$11.14	1,896	Officer	148,540	2025-01-31	Filing
Schoenberg	$11.14	1,896	Officer	147,103	2025-01-31	Filing
Schoenberg	$11.14	759	Officer	145,666	2025-01-31	Filing
Smith	$11.14	2,767	Officer	32,514	2025-01-31	Filing
Smith	$11.14	3,354	Officer	29,781	2025-01-31	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Rhumbline Advisers	53,466	$591,322	0%
2.	Versant Capital Management, Inc	858	$9,489	0%
3.	Gamma Investing Llc	7,499	$678	0%
4.	Rothschild Investment Llc	25	$277	0%
5.	Nbc Securities, Inc.	647	$7	0%